Clear Street’s Estrella Immunopharma ESLA Stock Holding History

Clear Street’s Portfolio ESLA Stock Details ESLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-29,709	Closed	-$322K	–	1172
2023 Q2	$322K	Buy	+29,709	New	+$321K	﹤0.01%	286

Other funds holding ESLA

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Clear Street's ESLA Position: Q3 2023 in Review

Clear Street sold out of Estrella Immunopharma (ESLA) in Q3 2023, closing a stake of 29,709 shares — an estimated $322K sold.

Clear Street first reported a position in ESLA in Q2 2023 and held it in 1 quarter. The position peaked at $322K in Q2 2023. 3 funds tracked by Wall St. Rank hold ESLA as of Q3 2023.

Clear Street reported no remaining Estrella Immunopharma position as of Q3 2023 after selling out during the quarter.
Clear Street sold 29,709 Estrella Immunopharma shares in Q3 2023, an estimated $322K.
Clear Street first reported a position in Estrella Immunopharma in Q2 2023 and held it in 1 quarter.
Clear Street's Estrella Immunopharma position peaked at $322K in Q2 2023.
3 funds tracked by Wall St. Rank held Estrella Immunopharma as of Q3 2023.

Based on Clear Street's 13F filing for Q3 2023, filed 13 Nov 2023.